Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

157
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
157
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

172
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
172
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

114
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
114
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

129
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
129
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

131
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
131
Obesity01:24

Obesity

1.0K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Negative effects of redundant targets.

Journal of experimental psychology. Human perception and performance·2026
Same author

Spatial selectivity in visual detection suffers when attention is divided.

Attention, perception & psychophysics·2025
Same author

Feasibility of forecasting future critical care bed availability using bed management data.

BMJ health & care informatics·2024
Same author

Efficacy and Safety of Peroral Endoscopic Myotomy (POEM) in Achalasia: An Updated Meta-analysis.

Middle East journal of digestive diseases·2024
Same author

A Ruthenium(II) Polypyridyl Complex Disrupts Actin Cytoskeleton Assembly and Blocks Cytokinesis.

Angewandte Chemie (Weinheim an der Bergstrasse, Germany)·2024
Same author

Testing hemifield independence for divided attention in visual object tasks.

Journal of vision·2023

Related Experiment Videos

Metabolic syndrome in the elderly.

Matthew Bechtold, John Palmer, Joshua Valtos

    Current Diabetes Reports
    |March 9, 2006
    PubMed
    Summary

    The global prevalence of metabolic syndrome is rising, particularly in the elderly. This condition, characterized by obesity and insulin resistance, significantly increases the risk of cardiovascular disease (CVD) in older adults.

    Area of Science:

    • Gerontology
    • Metabolic Disorders
    • Public Health

    Background:

    • Metabolic syndrome prevalence is increasing globally, with a notable rise in the elderly population.
    • Age-related physiological changes predispose older adults to intra-abdominal obesity and metabolic syndrome.
    • Metabolic syndrome is a cluster of conditions including obesity, insulin resistance, dyslipidemia, and hypertension.

    Purpose of the Study:

    • To highlight the growing concern of metabolic syndrome among the elderly.
    • To emphasize the increased risk of cardiovascular disease (CVD) and renal events in this demographic.
    • To underscore the need for proactive healthcare strategies regarding metabolic syndrome in aging populations.

    Main Methods:

    • This abstract does not detail specific methodologies.

    Related Experiment Videos

  • The content is a narrative review and statement of concern.
  • Focuses on epidemiological trends and clinical implications.

    • Main Results:

    • The elderly are at higher risk for metabolic syndrome and associated conditions like nonalcoholic steatohepatitis.
    • Metabolic syndrome significantly elevates the risk of cardiovascular disease (CVD) and renal events.
    • Without intervention, an epidemic of metabolic syndrome and CVD is projected among the elderly.

    Conclusions:

    • Metabolic syndrome poses a significant and growing threat to the elderly population.
    • Urgent attention from healthcare professionals, researchers, and clinicians is required.
    • Proactive and preventative measures are crucial to mitigate future health crises related to metabolic syndrome and CVD in older adults.